At this year’s exhibition, NEST presented its latest products and solutions, including pen injectors, prefilled syringes, and closed system solutions. The professional team engaged with global partners, introducing product features, technical strengths, and certifications — fully demonstrating NEST’s strong capability in pharmaceutical packaging solutions.
NEST’s pen injectors impressed visitors with precise dosing, user-friendly operation, and flexible customization. The prefilled syringes were recognized for high production efficiency and quality reliability, while the closed system solutions stood out for reducing contamination risks and improving manufacturing efficiency. Through this exhibition, NEST gained extensive attention, recognition, and established initial collaborations with several global pharmaceutical companies, laying a solid foundation for future international expansion.
This year’s CPHI gathered 2,400+ exhibitors and 62,000+ professionals from over 150 countries, covering every segment of the pharmaceutical supply chain — from APIs and biopharmaceuticals to machinery, packaging, and CDMO services. The China Pavilion, with 330 companies, stood as the largest international group, showcasing the strength and global ambitions of China’s pharmaceutical industry.
As CPHI Frankfurt 2025 concludes, the event continues to foster collaboration and innovation across the global pharmaceutical landscape. Looking ahead, NEST remains committed to driving progress in innovation, quality, and sustainable development, contributing to a healthier future for all.
Though the exhibition has ended, new partnerships are just beginning. We look forward to meeting you at the next destination — and shaping the future of pharmaceutical innovation together!
